Global Effervescent Tablet Market, By Products (Medication and Supplements), Methods (Dry Methods and Wet Granulation), Type (Prescription and Over the Counter), Indication (Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, and Others), Population Type (Children and Adults), Application (Dental Products, Dietary Supplements, Pharmaceutical, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Industry Trends and Forecast to 2031.
Effervescent Tablet Market Analysis and Size
The effervescent tablet market is experiencing significant growth, driven by several key factors. One of the major drivers is the increasing consumer preference for convenient dosage forms, as effervescent tablets offer a portable and easy-to-use alternative to traditional tablets or capsules. The pleasant taste and fizzy nature of effervescent tablets make them more appealing to consumers, especially children and older adults. Another factor driving the market growth is the growing demand for dietary supplements and vitamins. Effervescent tablets are popular for delivering these nutrients due to their quick dissolving nature and high bioavailability. The rise in health consciousness and the emphasis on preventive healthcare also contribute to the increasing demand for effervescent tablets.
The global effervescent tablet market size was valued at USD 9.78 billion in 2023 and is projected to reach USD 19.06 billion by 2031, with a CAGR of 8.7% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Medication and Supplements), Methods (Dry Methods and Wet Granulation), Type (Prescription and Over the Counter), Indication (Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, and Others), Population Type (Children and Adults), Application (Dental Products, Dietary Supplements, Pharmaceutical, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Perrigo Company plc (Ireland), Reckitt Benckiser Group PLC (U.K.), Bristol-Myers Squibb Company (U.S.), CHIESI SAS (France), Hermes Pharma (Austria), S. G. Biopharm Pvt. Ltd (India), Bliss GVS Pharma Limited (India), SCITECH (India), Alpex Solar (Switzerland), Vovantis Laboratories (India), Herbalife International of America, Inc. (U.S.), Swisse Wellness PTY LTD (Australia), Nuun (U.S.), Natur Produkt Zdrovit Sp Z O O (Poland), Vitabiotics Ltd (U.K.), Amerilab Technologies Inc. (U.S.), and HERMES ARZNEIMITTEL (Germany)
|
|
Market Opportunities
|
|
Market Definition
Effervescent tablets are formulated to quickly dissolve in water, releasing carbon dioxide gas. This creates a fizzy or effervescent solution, often used for medicinal purposes or as a dietary supplement. Effervescent tablets are typically used to deliver vitamins, minerals, and other active ingredients and are popular for their pleasant taste and ease of consumption.
Effervescent Tablet Market Dynamics
Drivers
- Growing Demand for Convenient Dosage Forms
The demand for convenient dosage forms, such as effervescent tablets, is rising as consumers seek easy-to-use and portable options. Effervescent tablets offer a convenient way to consume medications and supplements, as they can be dissolved in water and consumed as a refreshing drink. This ease of use makes effervescent tablets particularly popular among busy individuals looking for convenient solutions to meet their healthcare needs. In addition, the portability of effervescent tablets makes them ideal for on-the-go consumption, enabling consumers to conveniently take their medications or supplements on-the-go without requiring water or other beverages. As a result, the market for effervescent tablets is expected to continue growing.
- Rising Health Consciousness
The growing focus on health and wellness drives the demand for dietary supplements and vitamins, commonly delivered in effervescent tablets. Consumers are becoming more aware of the importance of maintaining a healthy lifestyle and are actively seeking ways to improve their overall well-being. This trend is particularly pronounced among the aging population, who seek ways to maintain their health and vitality as they age. Effervescent tablets offer a convenient and effective way to deliver essential nutrients, making them popular among health-conscious consumers. In addition, the pleasant taste and fizzy nature of effervescent tablets make them more appealing to consumers, further driving their popularity in the market.
Opportunities
- Increasing Urbanization
Urbanization is transforming lifestyles and dietary choices. As individuals migrate to urban regions, they encounter faster-paced routines and heightened stress levels, prompting a greater focus on health and well-being.Effervescent tablets offer a quick and easy way to supplement essential nutrients, making them an attractive option for urban dwellers looking to maintain their health amidst busy schedules, which is creating opportunities for market growth.
- Expanding Geriatric Population
Effervescent tablets are well-suited for the elderly, as they are easy to use and digest. With age, many individuals experience difficulties in swallowing pills or capsules, making effervescent tablets a more suitable option. Furthermore, effervescent tablets can be formulated to address common health issues the elderly faces, such as bone health, joint pain, and cognitive function. As the geriatric population grows, the demand for easy-to-use and effective dosage forms such as effervescent tablets is expected to rise.
Restraints/Challenges
- Competition from Other Dosage Forms
Effervescent tablets offer unique benefits such as quick dissolvability and pleasant taste. Traditional dosage forms are well-established in the market and are often preferred by consumers due to familiarity and perceived effectiveness. In addition, traditional tablets and capsules may have longer shelf lives and be more cost-effective to produce, making them a more attractive option for manufacturers. Effervescent tablet manufacturers must innovate continuously to differentiate their products and convince consumers of the benefits of their unique dosage form. These tablets encounter stiff competition from traditional tablets, capsules, and other dosage forms, hindering market growth.
- Environmental Concerns
The packaging and production of effervescent tablets can contribute to environmental issues, which may concern environmentally conscious consumers. The production of effervescent tablets often involves using plastics and other materials that are not easily recyclable, leading to waste generation. In addition, the packaging of effervescent tablets, such as individual foil packets or tubes, can result in excess packaging waste. As consumers become more aware of environmental issues, they may seek out products with minimal environmental impact, potentially leading to a shift away from effervescent tablets, which can be a challenge for the market.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the effervescent tablet market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2023, Bristol Myers Squibb (NYSE: BMY) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Opdivo (nivolumab) as a monotherapy for the adjuvant treatment of adults and adolescents aged 12 years and older with completely resected stage IIB or IIC melanoma. If approved, Opdivo would be the only PD-1 inhibitor indicated as an adjuvant treatment for patients within stages IIB, IIC, III, and stage IV resected melanoma, among two approvals
- In July 2023, Bayer and the Swiss Tropical and Public Health Institute (Swiss TPH) announced a collaboration to clinically develop the compound emodepside for treating humans infected with soil-transmitted helminths. This collaboration follows the promising results of a Phase II study conducted by Swiss TPH and its partners in Tanzania. The study, published on May 18, 2023, in the New England Journal of Medicine, demonstrated the efficacy of emodepside in patients with whipworm (Trichuris trichiura) and hookworm (Ancylostoma duodenale and Necator americanus) infections
Effervescent Tablet Market Scope
The market is segmented on the basis of products, methods, type, indication, application, population type, end user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Medication
- Supplements
Methods
- Dry Methods
- Wet Granulation
Type
- Prescription
- Over the Counter
Indication
- Diuretics
- Pain Management
- Gastric Disorders
- Respiratory Diseases
- Others
Population Type
- Children
- Adults
Application
- Dental Products
- Dietary Supplements
- Pharmaceutical
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Effervescent Tablet Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, products, methods, type, indication, application, population type, end user, and distribution channel as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
Europe is expected to dominate the market due to rising disposable incomes. In addition, the region's development of healthcare infrastructure and increased government initiatives are expected to accelerate market growth further.
North America is expected to witness significant growth during the forecast period due to increased research and development activities and a rise in healthcare spending, which will contribute to the market's growth. Furthermore, major market players in the region will further stimulate market expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The effervescent tablet market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for effervescent tablet market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the effervescent tablet market. The data is available for historic period 2011-2021.
Competitive Landscape and Effervescent Tablet Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Perrigo Company plc (Ireland)
- Reckitt Benckiser Group PLC (U.K.)
- Bristol-Myers Squibb Company (U.S.)
- CHIESI SAS (France)
- Hermes Pharma (Austria)
- S. G. Biopharm Pvt. Ltd (India)
- Bliss GVS Pharma Limited (India)
- Scitech (India)
- Alpex Solar (Switzerland)
- Vovantis Laboratories (India)
- Herbalife International of America, Inc. (U.S.)
- Swisse Wellness PTY LTD (Australia)
- Nuun (U.S.
- Natur Produkt Zdrovit Sp Z O O (Poland)
- Vitabiotics Ltd (U.K.)
- Amerilab Technologies Inc. (U.S.)
- HERMES ARZNEIMITTEL (Germany)
SKU-